Meetings - ISHLT Academy > Scientific Program


Saturday, April 24, 2:00 pm
- Sunday, April 25, Noon


CHAIRS: James K. Kirklin, MD and
              Mandeep R. Mehra, MD


This educational activity will offer 10
hours of intensive teaching activity
focusing on core competencies of
Advanced Heart Failure, Mechanical
Circulatory Support, Pulmonary
Hypertension and Cardiac Transplan-
tation. Registration for this Masters
Academy course is limited to the first
150 individuals. You may register via
the Official ISHLT Registration Form.
Registration for the ISHLT Annual
Meeting is NOT required in order to
register for this course.


Saturday, April 24, 2010
1:50 pm
Scientific Program
Opening Remarks


2:00 pm
SESSION 1:
Advanced Heart Failure and
High Risk Surgery


This session will cover the following
topics via lectures and panel discussion:


Advanced Heart Failure: Overview
  1) Diagnosis
  2) Etiology
  3) Approach to management
  4) Recent clinical trials and trials in
       progress
Heart Failure: Prognosis
  1) Individual prognostic markers and
       algorithms (SHFS, HFSS, EFFECT)
  2) Overview of CPET
Advanced Heart Failure: Treatment
  1) Current standard of care for treat-
       ment of advanced HF
  2) Timing of referral for advanced
       therapies (MCSD, Transplant, CRT)
Indications for CRT
  1) Evidence-based approach to patient
       selection and outcomes with CRT
  2) Overview of off-label indications includ-
       ing the difficult cases (RBBB, AFib)
End-of-Life Care
  1) Framework for assessing issues in
       patients with advanced HF nearing
       end of life
  2) Advanced care directives

4:15 pm  BREAK
4:30 pm
SESSION 2:
Mechanical Circulatory
Support


This session will cover the following
topics via lectures and panel discussion:


Indications for MCS
  1) Short-term versus long-term support
  2) Bridge to transplant, bridge to
       recovery, and destination therapy
  3) Left ventricular, right ventricular,
       and bi-ventricular support
  4) Bridge to transplant and destination
       therapy MCS criteria
The Influence of Patient Selection
on Outcomes

  1) Identification of co-morbidities
  2) INTERMACS Classifications
  3) Review of Lietz-Miller Risk Analysis
       of destination therapy patients
  4) SHFM
  5) Importance of prognostic models
  6) Correlation of risk factors and
       outcomes
Classification of Pumps
  1) Centrifugal, pulsatile and axial
  2) Percutaneous, implantable and
       paracorporeal
  3) Review of current FDA approved VADs
Surgical Nuances -
Intra-operative and Early Post-
Operative Management

  1) Operative Techniques
  2) Use of TEE intra-operatively
  3) RV Function
  4) Suction Events
  5) Ventricular Arrhythmias
  6) Pulmonary Hypertension
The Nuts and Bolts of Outpatient
Management

  1) Blood pressure assessment and
       management
  2) Anticoagulation regimens
  3) Diagnosis and Management of
       GI bleeding
  4) Thromboembolic Events
  5) Driveline Infections
  6) Non-device Related Infections

6:30 pm BREAK

7:00 pm
SESSION 3:
Dinner Session: Pictures Are
Worth A Thousand Words:
Imaging, Biopsies and
Hemodynamics


This session will cover the following
topics via case discussions and use of
an audience response system:


· Advanced Heart Failure
· Cardiac Allograft Vasculopathy
· Antibody Mediated Rejection
· Mechanical Circulatory Support
· Pulmonary Hypertension
Sunday, April 25, 2010
7:00 am
Continental Breakfast

7:30 am
SESSION 4:
Cardiac Transplantation


This session will cover the following
topics via lectures and panel discussion:


  1) Heart Transplant Candidacy
  2) Immediate Post-Transplant
       Care
  3) Immunosuppression
  4) Cellular and Antibody Mediated
       Rejection
  5) Cardiac Allograft Vasculopathy
  6) Infection/Nephropathy
  7) Other Complications
       (hypertension, hyperlipidemia,
       malignancy, diabetes, etc)

9:30 am BREAK

9:45 am
SESSION 5:
Pulmonary Hypertension


This session will cover the following
topics via lectures and panel discussion:


  1) Classification and overview of
       pathogenesis
  2) Diagnosis and end points for
       clinical management
  3) Physiology and pathophysiology
       of the Right Ventricle
  4) Managing the potential heart
       transplant recipient with a
       raised PVR
  5) Treatment of PAH - State of
       the Art Overview

11:45 am
CONCLUSION AND
ADJOURN

FACULTY AND STEERING
COMMITTEE MEMBERS


CO-CHAIR: James K. Kirklin, MD,
University of Alabama at Birmingham,
Birmingham, AL

CO-CHAIR: Mandeep R. Mehra, MD,
University of Maryland School of
Medicine, Baltimore, MD

Heather J. Ross, MD, FRCPC, Toronto
General Hospital, Toronto, CANADA

James B. Young, MD, Cleveland Clinic
Foundation, Cleveland, OH

John B. O'Connell, MD, St. Joseph's
Hospital, Atlanta, GA

Francis D. Pagani, MD, PhD, University of
Michigan Hospital, Ann Arbor, MI

Andreas O. Zuckermann, MD, University
of Vienna, Vienna, AUSTRIA

Roberta C. Bogaev, MD, FACC, Texas Heart
Institute, Houston, TX

Jayan Parameshwar, FRCP, Papworth
Hospital, Cambridge, UNITED KINGDOM

Jon Kobashigawa, MD, Cedars Sinai
Heart Institute, Los Angeles, CA

Patricia A. Uber, PharmD, University of
Maryland, Baltimore, MD

Paul A. Corris, MB FRCP, Freeman Hospital,
Newcastle Upon Tyne, UNITED KINGDOM

Myung H. Park, MD, University of Maryland
School of Medicine, Baltimore, MD

Allen S. Anderson, MD, University of
Chicago Medical Center, Chicago, IL

Anne I. Dipchand, MD, Hospital for Sick
Children, Toronto, CANADA

James F. George, PhD, University of
Alabama at Birmingham, Birmingham, AL
Text SizeIncrease Font SizeDecrease Font Size